
This Year in Primary Care: 10 Critical Updates in 2025
Stay informed with the latest critical updates, including new guidelines, vaccine insights, and groundbreaking research findings from 2025.
Given the amount of critical news from 2025, the editorial team at Patient Care Online has collected 10 of the most impactful headlines from the last 12 months, including FDA announcements, critical trial results, and key clinician insights. Catch up on anything you may have missed below.
1. American College of Gastroenterology Releases Updated Guidelines for Eosinophilic Esophagitis
The American College of Gastroenterology (ACG) has issued updated guidelines for diagnosing, treating, and monitoring
“This ACG clinical guideline is an update of the 2013 version,” Evan S. Dellon, MD, MPH, director, Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, and colleagues wrote in the American Journal of Gastroenterology. “Since that time, there have been paradigm-shifting changes in disease diagnosis and management, increases in knowledge about EoE risk factors, natural history and pathogenesis, development of validated outcome metrics, a disease severity classification system and updated nomenclature.”
2. The 5 Essential Adult Vaccines: What Your Patients Need to Know
A brief slideshow that focuses specifically on the
3. The 10 States with the Highest Risk for Cancer
A diagnosis of
Based on a composite score reflecting rates and concentrations of 9 such variables across US states, a recent study found South Dakota had the population at the greatest risk for developing cancer, with extremely high radon levels and excessive alcohol consumption the top contributing factors to the composite score of 99.9. At second highest risk was West Virginia (composite score 98.4), likely based on its claim to the highest rates of smoking and obesity among all states.
4. Vasomotor Symptoms of Menopause: Facts At-a-Glance for Primary Care
Hot flashes and night sweats are just 2 of the myriad symptoms associated with menopause. Click through a quick refresher on the transition and effective treatments.
5. What Are the 9 Influenza Vaccines Available for the 2025–2026 Respiratory Virus Season?
The CDC and the
For the 2025–2026 season, all US influenza vaccines are trivalent, covering 2 type A strains and 1 type B strain, according to the CDC. Based on recommendations made during the June meeting of the ACIP, the CDC advises use of
6. 7 Common Causes of Dementia: A Topline Review
The brain changes that lead to cognitive and behavioral changes referred to as dementia have multiple potential etiologies; not all dementia is Alzheimer disease.
7. Study: 72% of Asymptomatic UTI Patients Receive Unnecessary Antibiotics
A new study suggests that inappropriate antibiotic use for
Researchers from the University of Washington Center for Stewardship in Medicine found that nearly three-quarters of asymptomatic patients who underwent urine testing at participating hospitals were prescribed antibiotics, highlighting a significant opportunity for
8. When We Say "OX40 Inhibition," What Do We Mean? Emma Guttman-Yassky, MD, PhD, Explains
"What does it mean to target OX40 and the OX40 ligand pathway?" Emma Guttman-Yassky, MD, PhD, phrased the question like the veteran dermatology professor and researcher that she is, during a recent interview with Patient Care.©
9. Adult Vaccines in the US: More Shots, New Dynamics on the Horizon
The adult vaccine market is poised for explosive growth, with more than 100 product launches expected over the next 10 years. Are US clinicians ready?
10. LEO Pharma Announces Positive Preliminary Phase 2b Findings for Temtokibart in Atopic Dermatitis
Temtokibart (LEO 138559), an investigational monoclonal antibody targeting the IL-22RA1 receptor subunit, achieved statistically significant improvements in eczema severity at the 3 highest tested doses in a phase 2b clinical trial of adults with moderate-to-severe atopic dermatitis (AD), according to topline results announced by LEO Pharma.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
















































































































































































































































































